Skip to content

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

A2 Milk share price drops 14% even as FY19 profits hit $287 million

A2 Milk missed key earnings (EBITDA) estimates when it reported its FY19 results this morning. The stock was sold-off in response.

A2M share price falls on FY19 results Source: Bloomberg

FY19 results at a glance

a2 Milk Co Ltd (ASX: A2M) posted another set of highly impressive results with its FY19 release today.

The fresh milk and infant formula maker saw stellar growth across the board: with revenue, earnings and cash flow all continuing to rise in 2019.

Even so, when the NZX opened this morning at roughly 8:00 AEST – a2 Milk’s share price fell as much as 14.78%, to NZ$14.37 per share.

The company's share price fell slightly less when it opened on the ASX, dropping 11.75% as of 10:06 AEST.

Front-line financials march forward

Though the company’s share price fell this morning, a2 Milk Co Ltd’s CEO Jayne Hrdlicka spoke positively of the company’s record-breaking results, noting that revenue was strong across all of the company’s key products and regions.

Indeed, on a fundamental level, all of a2 Milk’s key FY19 financials came in strong.

On the top-line, revenue soared 41.4% to NZ$1,304 million.

Earnings also surged: EBITDA figures bounced 46.1%, while net profits after tax (NPAT) grew even faster, rising 47.0% to NZ$287.9 million.

In saying that, marketing costs did rise as the company aggressively expands. Here, a2 Milk’s marketing spend came in at NZ$135.3 million; an increase of 83.7% from the year prior.

So why the selloff then?

Though a2 Milk’s 2019 results were strong, they undershot analyst estimates in one key area: earnings.

Specifically, a2 Milk’s earnings (EBITDA) came in 2.7% below the average analyst consensus, according to Bloomberg Data.

Before the 2019 results announcement, analysts had been expecting earnings figures of between NZ$400 million and NZ$446 million – the company reported EBITDA of NZ$413.6 million, in comparison.

Such a miss was likely compounded by elevated expectations around the milk company going into the results.

Prior to the release, A2 Milk traded well above the market – with a price to earnings ratio of 47.8; compared to the ASX 200’s price to earnings ratio of 18.

Exiting the UK milk market

In an interesting development, a2 Milk Co Ltd today announced that it has decided to exit the UK liquid milk market, which it has decisively struggled to expand into in recent years.

On this topic, the company’s CEO Jayne Hrdlicka noted that the company is of the opinion that the ‘UK opportunity is not of sufficient scale.’

As such, Ms Hrdlicka further pointed out that, ‘the board has therefore decided to exit UK liquid milk operations during 1H20.’

Quantifying these struggles, and though a2 Milk’s U.K. business has seen some growth, it has been significantly slower going than the company’s other segments – rising just 12.7% in FY19 to A$21.6 million.

This pales in comparison to some of the company’s other markets. In the 2019 full-year for example: the US business segment saw its revenue increase 160%, China grew 73% and even the company’s Australian business – its most mature segment – grew 28.3% to NZ$847.2 million.

A2 Milk currently commands an impressive 6.4% of China’s infant nutrition market.

A2 Milk share price: outlook and opportunities

Even though a2 Milk’s shares were sold off aggressively this morning in New Zealand and Australia, there remains much to like about the infant formula and fresh milk company.

Speaking of the 2020 outlook, CEO Jayne Hrdlicka said:

‘We anticipate continued growth in revenue across our key regions supported by increasing brand and marketing investment in China and the US.’

Ms Hrdlicka continued by saying that:

‘We have also invested heavily in increasing our capability and capacity to support the development and delivery of comprehensive growth plans for our most important strategic priorities.’

In-line with such priorities, the company also anticipates that marketing spend will hit 12% of FY20 revenues – up from the 2019 year.

Going into the FY19 results and according to the Wall Street Journal: a2 Milk Co Ltd had six buy recommendations and three sell recommendations.

Ultimately, and even with the brutal sell-off we saw on the NZX this morning, a2 Milk's share price has still gained a massive 60.43% in the last year.

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.

Act on share opportunities today

Go long or short on thousands of international stocks with spread bets and CFDs.

  • Get full exposure for a comparatively small deposit
  • Trade on spreads from just 0.1%
  • Get greater order book visibility with direct market access

See opportunity on a stock?

Try a risk-free trade in your demo account, and see whether you’re on to something.

  • Log in to your demo
  • Take your position
  • See whether your hunch pays off

See opportunity on a stock?

Don’t miss your chance – upgrade to a live account to take advantage.

  • Trade a huge range of popular stocks
  • Analyse and deal seamlessly on fast, intuitive charts
  • See and react to breaking news in-platform

See opportunity on a stock?

Don’t miss your chance. Log in to take advantage while conditions prevail.

Live prices on most popular markets

  • Equities
  • Indices
  • Forex
  • Commodities
website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

" >


Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Sunday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.


For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.